Literature DB >> 34724097

Role of Akt isoforms in neuronal insulin signaling and resistance.

Medha Sharma1, Chinmoy Sankar Dey2.   

Abstract

The aim of the present study was to determine the role of Akt isoforms in insulin signaling and resistance in neuronal cells. By silencing Akt isoforms individually and in pairs, in Neuro-2a and HT22 cells we observed that, in insulin-sensitive condition, Akt isoforms differentially reduced activation of AS160 and glucose uptake with Akt2 playing the major role. Under insulin-resistant condition, phosphorylation of all isoforms and glucose uptake were severely affected. Over-expression of individual isoforms in insulin-sensitive and resistant cells differentially reversed AS160 phosphorylation with concomitant reversal in glucose uptake indicating a compensatory role of Akt isoforms in controlling neuronal insulin signaling. Post-insulin stimulation Akt2 translocated to the membrane the most followed by Akt3 and Akt1, decreasing glucose uptake in the similar order in insulin-sensitive cells. None of the Akt isoforms translocated in insulin-resistant cells or high-fat-diet mediated diabetic mice brain cells. Based on our data, insulin-dependent differential translocation of Akt isoforms to the plasma membrane turns out to be the key factor in determining Akt isoform specificity. Thus, isoforms play parallel with predominant role by Akt2, and compensatory yet novel role by Akt1 and Akt3 to regulate neuronal insulin signaling, glucose uptake, and insulin-resistance.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  AS160; Akt1; Akt2; Akt3; Neuronal insulin resistance; Neuronal insulin signaling

Mesh:

Substances:

Year:  2021        PMID: 34724097     DOI: 10.1007/s00018-021-03993-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  66 in total

1.  Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.

Authors:  Amit Gupta; Bharti Bisht; Chinmoy Sankar Dey
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

2.  Focal adhesion kinase negatively regulates neuronal insulin resistance.

Authors:  Amit Gupta; Bharti Bisht; Chinmoy Sankar Dey
Journal:  Biochim Biophys Acta       Date:  2012-02-18

Review 3.  Akt isoforms and glucose homeostasis - the leptin connection.

Authors:  Nissim Hay
Journal:  Trends Endocrinol Metab       Date:  2010-10-12       Impact factor: 12.015

Review 4.  The Akt kinases: isoform specificity in metabolism and cancer.

Authors:  Eva Gonzalez; Timothy E McGraw
Journal:  Cell Cycle       Date:  2009-08-23       Impact factor: 4.534

Review 5.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

6.  Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Diabetes Sci Technol       Date:  2008-11

7.  Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.

Authors:  Hung-Kai Chen; Pedro Fernandez-Funez; Summer F Acevedo; Yung C Lam; Michael D Kaytor; Michael H Fernandez; Alastair Aitken; Efthimios M C Skoulakis; Harry T Orr; Juan Botas; Huda Y Zoghbi
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

8.  The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.

Authors:  Sandrine Humbert; Elzbieta A Bryson; Fabrice P Cordelières; Nathan C Connors; Sandeep R Datta; Steven Finkbeiner; Michael E Greenberg; Frédéric Saudou
Journal:  Dev Cell       Date:  2002-06       Impact factor: 12.270

9.  PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance.

Authors:  Amit Gupta; Chinmoy Sankar Dey
Journal:  Mol Biol Cell       Date:  2012-08-08       Impact factor: 4.138

Review 10.  The PI3K/AKT pathway in obesity and type 2 diabetes.

Authors:  Xingjun Huang; Guihua Liu; Jiao Guo; Zhengquan Su
Journal:  Int J Biol Sci       Date:  2018-08-06       Impact factor: 6.580

View more
  1 in total

Review 1.  PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?

Authors:  Yan Peng; Yuanyuan Wang; Cheng Zhou; Wuxuan Mei; Changchun Zeng
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.